HOME
Search 2004 Abstracts
CCC 2004

Return to Main Menu

 

CHS Poster Session: Clinical Hypertension

 

001 - SUSTAINED JOB STRAIN AND HYPERTENSION: A PROSPECTIVE STUDY
C Guimont, C Brisson, GR Dagenais, A Milot, J Moisan, B Mâsse, M Vézina, A Vinet, N Laflamme
Quebec City, Quebec

002 - EMPLOYING GENE-GENE INTERACTIONS TO MAP A NEW QTL FOR BLOOD PRESSURE (BP) AND STUDIES OF CANDIDATE GENES ON DAHL RAT CHROMOSOME 2
J Dutil, J Tremblay, AY Deng
Montreal, Quebec

003 - SUSTAINED ANTIHYPERTENSIVE ACTIVITY OF TELMISARTAN VS VALSARTAN ON AMBULATORY BLOOD PRESSURE
Y Lacourciere, L Poirier, JM Krzesinski, WB White, G Davidai, L Oostvogel, H Schumacher
Quebec City, Quebec; Liege, Belgium; Farmington, Connecticut, USA

004 - DOES HYPERTENSION PRODUCE AORTIC VALVE SCLEROSIS?
SW Rabkin
Vancouver, British Columbia

005 - AMBULATORY SYSTOLIC BLOOD PRESSURE IS MORE EFFECTIVE AT PREDICTING MORTALITY THAN CLINIC BLOOD PRESSURE
MG Dawes, AJ Coats, E Juszczak
Montreal, Quebec

006 - ALLELIC ASSOCIATION OF Anp AND Npr1 GENES WITH HYPERTENSION IS IMPACTED BY BMI
K Faldik, PL Brunelle, C Podjaski, F Gossard, D Gaudet, G Tremblay, TA Kotchen, P Hamet, J Tremblay
Montreal, Quebec; Chicoutimi, Quebec; Milwaukee, Wisconsin, USA

007 - NON COMPLIANCE IN HYPERTENSIVE PATIENTS: IMPACT OF SOCIOMEDICAL FACTORS AND REPRESENTATIONS
M Proulx, N Leduc, L Vandelac, J-P Grégoire, R Guibert
Montreal, Quebec; Quebec City, Quebec

008 - IMPLEMENTING RECOMMENDATIONS ON HYPERTENSION: A CANADIAN EXPERIENCE
D Drouin, R Feldman, N Campbell, S Tobe
Quebec City, Quebec

009 - AGE- AND SEX-SPECIFIC REFERENCE RANGES FOR SYSTOLIC, DIASTOLIC AND PULSE PRESSURE, AND WITHIN SUBJECT VARIABILITY OF 3 REPEATED BLOOD PRESSURE MEASUREMENTS
JJ Macnab, W Clark

010 - GENES INVOLVED IN OXYTOCIN-INDUCED CARDIOMYOGENESIS
BA Danalache, J Paquin, M Jankowski, J Gutkowska
Montreal, Quebec

011 - ADENOSINE BLOCKADE WITH CAFFEINE INCREASES THE EXERCISE DURATION OF HEART FAILURE PATIENTS
CF Notarius, BL Morris, JS Floras
Toronto, Ontario

012 - THE COMMUNITY HYPERTENSION ASSESSMENT TRIAL (CHAT)
L Chambers, J Kaczorowski, C Levitt, W Hogg, T Karwalajtys, A Hendriks, CH [*full name?*] on behalf of the CHAT Working Group
Hamilton, Ontario; Ottawa, Ontario

013 - POLYMORPHISM IN ACE2 GENE IS ASSOCIATED WITH HYPERTENSION AND HYPERTENSION RELATED PHENOTYPES IN FRENCH CANADIANS
M Labuda, J Uwabo, Y Sun, D Gaudet, F Gossard, Z Pausova, T Kotchen, AW Cowley, J Tremblay, P Hamet
Montreal, Quebec; Milwaukee, Wisconsin, USA; Chicoutimi, Quebec

014 - IDENTIFICATION OF A DYSFUNCTIONAL MISSENSE SINGLE NUCLEOTIDE VARIANT OF HUMAN ADENYLYL CYCLASE VI
R Gros, QM Ding, H Cao, T Main, R Hegele, RD Feldman
London, Ontario

015 - NON-INVASIVE HEMODYNAMIC MONITORING IN PATIENTS WITH HYPERTENSION: A VALIDATION STUDY
JA McFetridge
Halifax, Nova Scotia

016 - HEART FAILURE RESULTS IN THE ANTIHYPERTENSIVE AND LIPID-LOWERING TREATMENT TO PREVENT HEART ATTACK TRIAL
BR Davis, FH Leenen
Bethesda, Maryland, USA

017 - HOME BLOOD PRESSURE MEASUREMENT: THE ARCHER OR THE ARROW?
T Stryker, M Wilson, TW Wilson
Saskatoon, Saskatchewan

018 - ANTIHYPERTENSIVE THERAPY AND INCIDENCE OF TYPE 2 DIABETES IN AN ELDERLY COHORT
RS Padwal, M Mamdani, DA Alter, JE Hux, DM Rothwell, K Tu, A Laupacis
Edmonton, Alberta; Toronto, Ontario